SC 19220 - CAS 19395-87-0
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C16H14ClN3O3
Molecular Weight:
331.76
COA:
Inquire
Targets:
Prostanoid Receptor
Description:
SC 19220 is a selective EP1 receptor antagonist (IC50 = 6.7 μM for inhibition of [3H]-PGE2 binding to EP1 transfected COS cells). SC-19220 acts as a PGE2 antagonist in the EP1 receptor-mediated contraction of guinea pig trachea.
Brife Description:
EP1 prostanoid receptor antagonist
Purity:
≥99% by HPLC
Synonyms:
SC-19220; SC 19220; SC19220. 8-Chloro-dibenzo(Z)[b,f][1,4]oxazepine-10(11H)-carboxylic acid, 2-acetylhydrazide; N'-acetyl-3-chloro-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide
MSDS:
Inquire
InChIKey:
KNURFLJTOUGOOQ-UHFFFAOYSA-N
InChI:
InChI=1S/C16H14ClN3O3/c1-10(21)18-19-16(22)20-9-11-4-2-3-5-14(11)23-15-7-6-12(17)8-13(15)20/h2-8H,9H2,1H3,(H,18,21)(H,19,22)
Canonical SMILES:
CC(=O)NNC(=O)N1CC2=CC=CC=C2OC3=C1C=C(C=C3)Cl
1.Isolation of a haemorrhagic protein toxin (SA-HT) from the Indian venomous butterfish (Scatophagus argus, Linn) sting extract.
Karmakar S;Muhuri DC;Dasgupta SC;Nagchaudhuri AK;Gomes A Indian J Exp Biol. 2004 May;42(5):452-60.
A haemorrhagic protein toxin (SA-HT) was isolated and purified from the spine extract of the Indian venomous butterfish, S. argus Linn, by two step ion exchange chromatography. The toxin was homogeneous in native and SDS-PAGE gel. SDS-molecular weight of the toxin was found to be 18.1 +/- 0.09 kDa. SA-HT produced severe haemorrhage on stomach wall but devoid of cutaneous haemorrhage. UV, EDTA, trypsin, protease, cyproheptadine, indomethacin, acetylsalicylic acid and BW755C treatment significantly antagonized the haemorrhagic activity of SA-HT. The toxin produced dose and time dependent oedema on mice hind paw, which was significantly encountered by cyproheptadine, indomethacin and BW755C. SA-HT increased capillary permeability on guinea pig dorsal flank. On isolated guineapig ileum, rat fundus and uterus, SA-HT produced slow contraction which was completely antagonised by prostaglandin blocker SC19220. On isolated rat duodenum, SA-HT produced slow relaxation. SA-HT significantly increased plasma plasmin, serum MDA level and decreased serum SOD level indicating the possible involvement of cyclooxygenase and lipooxygenase pathway.
2.Phospholipase A2 activating protein (PLAA) is required for 1alpha,25(OH)2D3 signaling in growth plate chondrocytes.
Schwartz Z;Graham EJ;Wang L;Lossdörfer S;Gay I;Johnson-Pais TL;Carnes DL;Sylvia VL;Boyan BD J Cell Physiol. 2005 Apr;203(1):54-70.
Phospholipase A2 (PLA2) is pivotal in the rapid membrane-mediated actions of 1,25-dihydroxyvitamin D3 [1alpha,25(OH)2D3]. Microarray analysis indicated that PLA2 activating protein (PLAA) mRNA is upregulated 6-fold before rat growth plate cells exhibit 1alpha,25(OH)2D3-dependent protein kinase C (PKC) increases, suggesting that it plays an important role in 1alpha,25(OH)2D3's mechanism of action. PLAA mRNA was confirmed in 1alpha,25(OH)2D3-responsive growth zone (prehypertrophic and upper hypertrophic cell zones) chondrocytes by RT-PCR and Northern blot in vitro and by in situ hybridization in vivo. PLAA protein was shown by Western blot and immunohistochemistry. PLAAs role in 1alpha,25(OH)2D3 signaling was evaluated in growth zone cell cultures using PLAA peptide. Arachidonic acid release was increased as was PLA2-specific activity in plasma membranes and matrix vesicles. PKCalpha, but not PKCbeta, PKCepsilon, or PKCzeta, was increased. PLAAs effect was comparable to that of 1alpha,25(OH)2D3 and was additive with 1alpha,25(OH)2D3. PLA2 inhibitors quinacrine and AACOCF3, and cyclooxygenase inhibitor indomethacin blocked the effect of PLAA peptide on PKC, indicating arachidonic acid and its metabolites were involved.
3.Intermolecular cross-talk between the prostaglandin E2 receptor (EP)3 of subtype and thromboxane A(2) receptor signalling in human erythroleukaemic cells.
Reid HM;Kinsella BT Br J Pharmacol. 2009 Oct;158(3):830-47. doi: 10.1111/j.1476-5381.2009.00351.x. Epub 2009 Aug 20.
BACKGROUND AND PURPOSE: ;In previous studies investigating cross-talk of signalling between prostaglandin (PG)E(2) receptor (EP) and the TPalpha and TPbeta isoforms of the human thromboxane (TX)A(2) receptor (TP), 17-phenyl trinor PGE(2)-induced desensitization of TP receptor signalling through activation of the AH6809 and SC19220-sensitive EP(1) subtype of the EP receptor family, in a cell-specific manner. Here, we sought to further investigate that cross-talk in human erythroleukaemic (HEL) 92.1.7 cells.;EXPERIMENTAL APPROACH: ;Specificity of 17-phenyl trinor PGE(2) signalling and its possible cross-talk with signalling by TPalpha/TPbeta receptors endogenously expressed in HEL cells was examined through assessment of agonist-induced inositol 1,4,5-trisphosphate (IP)(3) generation and intracellular calcium ([Ca(2+)](i)) mobilization.;KEY RESULTS: ;While 17-Phenyl trinor PGE(2) led to activation of phospholipase (PL)Cbeta to yield increases in IP(3) generation and [Ca(2+)](i), it did not desensitize but rather augmented that signalling in response to subsequent stimulation with the TXA(2) mimetic U46619. Furthermore, the augmentation was reciprocal. Signalling by 17-phenyl trinor PGE(2) was found to occur through AH6809- and SC19920-insensitive, Pertussis toxin-sensitive, G(i)/G(betagamma)-dependent activation of PLCbeta.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Prostanoid Receptor Products


CAS 459841-96-4 ONO 8130

ONO 8130
(CAS: 459841-96-4)

ONO 8130 is a prostanoid EP1 receptor antagonist. It can relieve bladder pain in mice with cyclophosphamide-induced cystitis.

CAS 346673-06-1 TCS 2510

TCS 2510
(CAS: 346673-06-1)

TCS 2510 is a selective EP4 agonist (EC50 = 2.5 nM; Ki = 1.2 nM) that displays no significant binding at other prostaglandin receptors at concentrations up to 1...

CAS 363-24-6 Prostaglandin E2

Prostaglandin E2
(CAS: 363-24-6)

Binds with high affinity to EP1, EP2, EP3 and EP4 receptors (Kd values range between ~ 1 - 10 nM), Prostaglandin E2 is one of the primary COX products of arachi...

CAS 146032-79-3 SC 51322

SC 51322
(CAS: 146032-79-3)

SC 51322 is a potent EP1 prostanoid receptor antagonist (Ki = 13.8 nM) with analgesic properties in vivo. SC 51322 inhibits PGE2 signaling in a guinea pig ileum...

CAS 475086-01-2 NS-304

NS-304
(CAS: 475086-01-2)

NS-304 is a selective prostacyclin IP1 receptor agonist as prodrug of the active form of MRE-269 with a Ki value of 20 nM.

CAS 60325-46-4 Sulprostone

Sulprostone
(CAS: 60325-46-4)

Sulprostone is a synthetic PGE2 analog that acts as a selective EP3 and EP1 receptor agonist (Ki = 0.6 and 21 nM, respectively). Sulprostone is a potent stimula...

CAS 33458-93-4 AH 6809

AH 6809
(CAS: 33458-93-4)

AH 6809 is an EP1 (pA2 = 6.8) and EP2 (Ki = 350 nM) receptor antagonist.

S-110483

S-110483 is a prostanoid EP4 receptor antagonist with immunomodulatory and analgesic activities. Human EP4 receptor binding assays showed a Ki value of 0.73 nmo...

Chemical Structure

CAS 19395-87-0 SC 19220

Quick Inquiry

Verification code

Featured Items